Abdol Aziz Ould Ismail

Dr. Abdol Aziz Ould Ismail


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JWJiexi Wen
Jiexi Wen
JYJie Zeng Yu
Jie Zeng Yu
CLCatherine Liu
Catherine Liu
AIAbdol Aziz Ould Ismail
Abdol Aziz Ould Ismail
Weijie MaWeijie Ma
Weijie Ma
Brain metastases represent a significant clinical challenge in the treatment of non-small-cell lung cancer (NSCLC), often leading to a severe decline in patient prognosis and survival. Recent advances in imaging and systemic treatments have increased the detection rates of brain metastases, yet clinical outcomes remain dismal due to the complexity of the metastatic tumor microenvironment (TME) and the lack of specific biomarkers for early detection and targeted therapy. The intricate interplay between NSCLC tumor cells and the surrounding TME in brain metastases is pivotal, influencing tumor progression, immune evasion, and response to therapy. This underscores the necessity for a deeper understanding of the molecular underpinnings of brain metastases, tumor microenvironment, and the identification of actionable biomarkers that can inform multimodal treatment approaches. The goal of this review is to synthesize current insights into the TME and elucidate molecular mechanisms in NSCLC brain metastases. Furthermore, we will explore the promising horizon of emerging biomarkers, both tissue- and liquid-based, that hold the potential to radically transform the treatment strategies and the enhancement of patient outcomes.

13 May 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
COChiamaka L Okorie
Chiamaka L Okorie
EGElise Gatsby
Elise Gatsby
FSFlorian R. Schroeck
Florian R. Schroeck
AIAbdol Aziz Ould Ismail
Abdol Aziz Ould Ismail
KLKristine E. Lynch
Kristine E. Lynch
Background: Healthcare providers are often targeted as research participants, especially for implementation science studies evaluating provider- or system-level issues. Frequently, provider eligibility is based on both provider and patient factors. Manual chart review and self-report are common provider screening strategies but require substantial time, effort, and resources. The automated use of electronic health record (EHR) data may streamline provider identification for implementation science research. Here, we describe an approach to provider screening for a Veterans Health Administration (VHA)-funded study focused on implementing risk-aligned surveillance for bladder cancer patients. Methods: Our goal was to identify providers at 6 pre-specified facilities who performed ≥10 surveillance cystoscopy procedures among bladder cancer patients in the 12 months prior to recruitment start on January 16, 2020, and who were currently practicing at 1 of 6 pre-specified facilities. Using VHA EHR data (using CPT, ICD10 procedure, and ICD10 diagnosis codes), we identified cystoscopy procedures performed after an initial bladder cancer diagnosis (i.e., surveillance procedures). Procedures were linked to VHA staff data to determine the provider of record, the number of cystoscopies they performed, and their current location of practice. To validate this approach, we performed a chart review of 105 procedures performed by a random sample of identified providers. The proportion of correctly identified procedures was calculated (Positive Predictive Value (PPV)), along with binomial 95% confidence intervals (CI). Findings: We identified 1,917,856 cystoscopies performed on 703,324 patients from October 1, 1999—January 16, 2020, across the nationwide VHA. Of those procedures, 40% were done on patients who had a prior record of bladder cancer and were completed by 15,065 distinct providers. Of those, 61 performed ≥ 10 procedures and were currently practicing at 1 of the 6 facilities of interest in the 1 year prior to study recruitment. The random chart review of 7 providers found 101 of 105 procedures (PPV: 96%; 95% CI: 91% to 99%) were surveillance procedures and were performed by the selected provider on the recorded date. Implications: These results show that EHR data can be used for accurate identification of healthcare providers as research participants when inclusion criteria consist of both patient- (temporal relationship between diagnosis and procedure) and provider-level (frequency of procedure and location of current practice) factors. As administrative codes and provider identifiers are collected in most, if not all, EHRs for billing purposes this approach can be translated from provider recruitment in VHA to other healthcare systems. Implementation studies should consider this method of screening providers.

23 April 2026 in Head & Neck
Verified
Journal Article
Closed access
AIAbdol Aziz Ould Ismail
Abdol Aziz Ould Ismail
JPJason R. Pettus
Jason R. Pettus
LTLaura J. Tafe
Laura J. Tafe
CBCandice C. Black
Candice C. Black
SSShannon N. Schutz
Shannon N. Schutz
DKDarcy A. Kerr
Darcy A. Kerr

17 June 2026 in Academic Pathology
Verified
Journal Article
Open access
AIAbdol Aziz Ould Ismail
Abdol Aziz Ould Ismail
WMWeijie Ma
Weijie Ma
NDNancy M. Dunbar
Nancy M. Dunbar
KGK. Aaron Geno
K. Aaron Geno
JKJeremiah X. Karrs
Jeremiah X. Karrs
IMIsabella Martin
Isabella Martin
Large language models are increasingly applied in medical education, but their role in clinical pathology remains uncertain. We conducted a prospective evaluation during the 2024–2025 academic year using GPT-4 with a standardized prompting protocol to generate multiple-choice questions for pathology resident education in clinical chemistry, hematopathology, clinical microbiology, molecular pathology, bioinformatics, and transfusion medicine. Faculty experts scored items for clarity and accuracy on a 1–5 scale and assigned a disposition of kept as is, kept but edited, or discarded. Of 260 items reviewed, 108 (41.5%) were retained without revision, 86 (33.1%) with edits, and 66 (25.4%) were discarded. Subspecialty performance varied, with molecular pathology showing the highest retention (60% unedited), while clinical microbiology had a relatively high discard rate (41.7%). Items retained without revision demonstrated significantly higher clarity and accuracy scores than discarded items (P < 0.05), and quality metrics also varied significantly across subspecialties (P < 0.001). Higher clarity (odds ratio: 1.68, 95% confidence interval: 1.12–2.54, P = 0.013) significantly predicted favorable disposition. Faculty comments revealed that AI-generated questions most often failed due to inappropriate difficulty calibration, lack of board relevance, and a disconnect from real-world laboratory practices. Reviewers favored practical, application-focused content over factual recall. Nearly three-quarters of artificial intelligence-generated questions were usable after expert review, highlighting the potential of large language models to accelerate assessment development. However, uneven subspecialty performance and risks of regulatory misalignment underscore the necessity of sustained expert oversight.